daidzin has been researched along with thyroxine in 1 studies
Studies (daidzin) | Trials (daidzin) | Recent Studies (post-2010) (daidzin) | Studies (thyroxine) | Trials (thyroxine) | Recent Studies (post-2010) (thyroxine) |
---|---|---|---|---|---|
226 | 6 | 105 | 38,989 | 1,410 | 6,550 |
Protein | Taxonomy | daidzin (IC50) | thyroxine (IC50) |
---|---|---|---|
Transthyretin | Homo sapiens (human) | 2.1939 | |
UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 5.25 | |
Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 8 | |
Bile acid receptor | Homo sapiens (human) | 7.86 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbetta, B; Benvenuti, C; Colovic, M; Donazzolo, Y; Giacovelli, G; Manzotti, C; Persiani, S; Rovati, LC; Sala, F; Vitalini, C; Zangarini, M | 1 |
1 trial(s) available for daidzin and thyroxine
Article | Year |
---|---|
Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.
Topics: Administration, Oral; Biological Availability; Cross-Over Studies; Dietary Supplements; Equol; Female; Glycine max; Humans; Isoflavones; Middle Aged; Postmenopause; Therapeutic Equivalency; Thyroxine | 2016 |